Vanguard Global Advisers
AVXL icon

Vanguard Global Advisers’s Anavex Life Sciences AVXL Stock Holding History

Vanguard Global Advisers’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.3K Hold
34,108
– – ﹤0.01% 2829
2026
Q1 		$105K Buy
+34,108
New +$148K ﹤0.01% 2709

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Global Advisers's AVXL Position: Q2 2026 in Review

Vanguard Global Advisers held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 34,108 shares worth $88.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

Vanguard Global Advisers first reported a position in AVXL in Q1 2026 and has held it in 2 quarters since. The position peaked at $105K in Q1 2026. 175 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Vanguard Global Advisers held 34,108 shares of Anavex Life Sciences worth $88.3K as of Q2 2026.
  • Vanguard Global Advisers left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2829 holding.
  • Vanguard Global Advisers first reported a position in Anavex Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Anavex Life Sciences position peaked at $105K in Q1 2026.
  • 175 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.